Literature DB >> 3111757

Fatty acid composition of phospholipids in bile in man: promoting effect of deoxycholate on arachidonate.

G P van Berge Henegouwen, S D van der Werf, A T Ruben.   

Abstract

Ninety-five percent of phospholipids (PLs) in bile is secreted as phosphatidylcholine or lecithin. The study of fatty acid patterns of phospholipids present in gallbladder bile could help clarify whether a preponderance of certain fatty acids could play a role in cholesterol gallstone formation in man. In acute bile acid-exchange experiments, it was found that more hydrophobic bile acids did promote the excretion in bile of PL rich in arachidonic acid (a prostaglandin precursor) and stearic acid. We studied, therefore, bile acid, cholesterol and phospholipid fatty acid patterns (measured by gas chromatography) in gallbladder bile, obtained by duodenal intubation and cholecystokinin-stimulation of 24 healthy volunteers with normal liver/gallbladder function (ultrasound). PL-fatty acid composition (mean % +/- SD) was 41.40 (+/- 1.41) for palmitic acid, 2.68 (+/- 0.82) for palmitoleic acid, 5.50 (+/- 1.55) for stearic acid, 12.09 (+/- 0.98) for oleic acid, 32.83 (+/- 3.04) for linoleic acid and 5.64 (+/- 1.59) for arachidonic acid. The proportion of biliary deoxycholate was positively correlated with arachidonic acid (r = 0.71; p less than 0.01), whereas chenodeoxycholate was inversely correlated with arachidonic acid (r = -0.53; p less than 0.01). There was a positive correlation between biliary chenodeoxycholate and linoleic acid (r = 0.48; p less than 0.05) and a negative correlation between biliary deoxycholate and linoleic acid composition (r = 0.68; p less than 0.01). Also a correlation was found between palmitic acid and cholesterol saturation index (r = 0.49; p less than 0.05). We conclude that the hydrophobic bile acid deoxycholate, which does not desaturate cholesterol in bile, promotes the biliary excretion of arachidonic acid. Since arachidonic acid could induce the gallbladder mucosa to produce prostaglandins and mucus, increased biliary PL-arachidonic acid composition might be a factor in cholesterol gallstone disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111757     DOI: 10.1016/0009-8981(87)90215-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  12 in total

1.  Roles of deoxycholate and arachidonate in pathogenesis of cholesterol gallstones in obese patients during rapid loss of weight.

Authors:  J W Marks; G G Bonorris; L J Schoenfield
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 2.  Deoxycholic acid and the pathogenesis of gall stones.

Authors:  S N Marcus; K W Heaton
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

3.  Partial replacement of bile salts causes marked changes of cholesterol crystallization in supersaturated model bile systems.

Authors:  T Nishioka; S Tazuma; G Yamashita; G Kajiyama
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

4.  Mechanism for inhibition of Vibrio cholerae ToxT activity by the unsaturated fatty acid components of bile.

Authors:  Sarah C Plecha; Jeffrey H Withey
Journal:  J Bacteriol       Date:  2015-03-02       Impact factor: 3.490

5.  Cholelithiatic human gallbladders in vitro fail to respond to cholecystokinin but are responsive to carbachol, histamine, or electrical stimulation.

Authors:  Shripad B Deshpande; Narendra K Gupta; Vijay K Shukla
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

6.  Prevention of cholesterol cholelithiasis by dietary unsaturated fats in hormone-treated female hamsters.

Authors:  N Ayyad; B I Cohen; A Ohshima; E H Mosbach
Journal:  Lipids       Date:  1996-07       Impact factor: 1.880

7.  Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.

Authors:  H Noshiro; K Chijiiwa; I Makino; K Nakano; I Hirota
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

8.  Effect of phospholipids and their molecular species on cholesterol solubility and nucleation in human and model biles.

Authors:  Z Halpern; M Moshkowitz; H Laufer; Y Peled; T Gilat
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

9.  Effect of NSAIDs on gallbladder bile composition.

Authors:  R K Sterling; M L Shiffman; H J Sugerman; E W Moore
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

Review 10.  The gallstone story.

Authors:  R H Dowling
Journal:  Ulster Med J       Date:  1998-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.